• tBID as a BAX-Like Effector of Apoptosis

  2026-09-20

  The reference study shows that truncated BID (tBID) can directly permeabilize the mitochondrial outer membrane, even when the canonical effectors BAX and BAK are absent or inactive. This finding expands the functional classification of BCL-2-family proteins and provides a mechanistic explanation for apoptosis and SMAC release in selected infection and leukemia contexts, including cells with acquired venetoclax resistance.

• 2-Hydroxypropyl-β-cyclodextrin Workflow Guide

  2026-09-19

  2-Hydroxypropyl-β-cyclodextrin is a water-soluble cyclic oligosaccharide used to improve the aqueous handling of poorly soluble hydrophobic compounds, especially molecules containing aromatic or phenyl groups. It is appropriate for validated formulation and biochemical solubility workflows, but solubility improvement alone does not establish bioavailability, efficacy, safety, or therapeutic suitability.

• BAY-826 Workflows for Angiogenesis Research

  2026-09-18

  BAY-826 provides a high-potency chemical perturbation for separating angiopoietin-dependent signaling from Müller cell-mediated retinal neuron survival. This workflow combines controlled dosing with co-culture, hypoxia, phospho-signaling, PEDF, and genetic validation to improve mechanistic resolution.

• CRTC–CREB Senses Proteotoxic Stress in Drosophila

  2026-09-18

  The reference study identifies CRTC–CREB as a stress-responsive transcriptional system activated by proteasome inhibition through ROS and JNK. Its genetic, transcriptomic, and disease-model experiments show that enhancing this pathway improves proteostasis and suppresses Huntington’s disease phenotypes in Drosophila, while also defining important limits for translation to mammalian and oncology research.

• Dehydroepiandrosterone (DHEA): Mechanisms & Uses

  2026-09-17

  Dehydroepiandrosterone (DHEA) is an endogenous steroid precursor and neurosteroid used to study neuroprotection, apoptosis inhibition, neural stem-cell biology, and ovarian models. Its research value depends on separating cell-survival benchmarks from endocrine-model induction, especially in DHEA-induced polycystic ovary syndrome studies.

• UBR1 and UBR2 in Mammalian ER Stress Sensing

  2026-09-17

  The reference study identifies the N-recognin E3 ligases UBR1 and UBR2 as stress-responsive regulators of mammalian protein quality control. Its findings connect N-degron pathway activity with ER stress adaptation and show that loss of either factor increases susceptibility to ER stress-induced apoptosis.

• Total RNA Extraction Reagent (Trizol) for Bacillus Studies

  2026-09-16

  Total RNA Extraction Reagent (Trizol) can connect transcriptional evidence with protein-engineering outcomes in Bacillus enzyme production. This article explains how an RNA-centered workflow complements the 2026 protein-glutaminase study without confusing transcript abundance with catalytic performance.

• Topotecan in First-Line Small Cell Lung Cancer

  2026-09-16

  This clinical review evaluates whether topotecan-based combinations could extend first-line treatment options for small cell lung cancer beyond cisplatin and etoposide. Its main contribution is a structured interpretation of early phase II evidence, highlighting promising response rates while emphasizing that toxicity, disease extent, and the absence of definitive survival comparisons limit conclusions about replacing standard therapy.

• Verapamil HCl as a Mechanistic Probe of Bone Turnover

  2026-09-15

  Verapamil HCl is more than an L-type calcium channel blocker: it can serve as a mechanistic probe linking calcium flux with Txnip-regulated bone remodeling. This guide translates recent osteoporosis findings into better assay design across bone, myeloma, and inflammatory disease models.

• Cy3 Goat Anti-Rabbit IgG (H+L) Antibody

  2026-09-15

  Cy3 Goat Anti-Rabbit IgG (H+L) Antibody provides fluorescent detection of rabbit primary antibodies in immunofluorescence, immunohistochemistry, immunocytochemistry, and related assays. This guide covers handling, assay setup, controls, and troubleshooting; product-specific working dilutions and performance in particular specimens should be established experimentally.

• Imipenem Research Workflows: Setup to Troubleshooting

  2026-09-14

  Build reproducible Imipenem workflows for antibacterial research, immune response modulation, and sepsis animal model studies. The guide combines PBP-centered assay design, water-based preparation, time-course thinking, and troubleshooting for bacterial and host-cell readouts.

• HBsAg, TBK1, and Autophagy in HBV Immune Evasion

  2026-09-14

  The reference study identifies a previously underappreciated mechanism by which hepatitis B surface antigen redirects TBK1 activity away from IRF3-dependent interferon signaling and toward early, incomplete autophagy. Its combination of molecular interaction studies, pharmacological perturbation, animal validation, and human liver-tissue analysis provides a framework for understanding how HBV may establish persistent infection.

• Amikacin (BAY416651) in Resistance Research

  2026-09-13

  A translational framework for using Amikacin (BAY416651) to connect ribosomal mechanism, aminoglycoside resistance, plasmid mobility, and experimental decision-making in carbapenem-resistant Enterobacterales research.

• Nutlin-3a: MDM2 Inhibitor and p53 Tool

  2026-09-12

  Nutlin-3a is a small-molecule MDM2 inhibitor that prevents MDM2 engagement with the TP53-binding pocket and supports p53 pathway activation. Product data report a 0.09 μM MDM2 IC50, while cellular responses vary with p53 status, model, exposure, and assay design.

• Aminopeptidase Selectivity and ACE Inhibitor Action

  2026-09-11

  The reference study re-evaluated how bestatin and several metallopeptidase inhibitors affect the related cell-surface aminopeptidases AP-A, AP-N, and AP-W. Its side-by-side analysis exposed substantial selectivity differences, including preferential AP-N inhibition by actinonin and AP-W inhibition by sulfhydryl ACE inhibitors, which is important when interpreting inhibitor-based experiments.

8514 records 1/568 page Next 12345 下5页 Last page